Collaborate for a Healthier Future. Discover how Fortrea and our global site partners are driving innovation in clinical trials. https://lnkd.in/e6uF8Zuj
Fortrea的动态
最相关的动态
-
?? Did you know that DynaMedex? supports local language search, and content includes international drug names, as well as the latest guidance from a wide variety of international guideline organizations? See how #DynaMedex supports clinicians around the world: https://lnkd.in/e4YpiPf4 #ClinicalDecisionSupport #EvidenceBasedMedicine
要查看或添加评论,请登录
-
As the go-to CRO partner for biotech visionaries, our therapeutic expertise moves you forward, scales you further, and maximizes your patient impact. Discover our passion for yourself. https://bit.ly/40e5uLS #therapeuticexpertise #patientcentric #patientimpact
要查看或添加评论,请登录
-
As the go-to CRO partner for biotech visionaries, our therapeutic expertise moves you forward, scales you further, and maximizes your patient impact. Discover our passion for yourself. https://bit.ly/3U1b81D #therapeuticexpertise #patientcentric #patientimpact
要查看或添加评论,请登录
-
As the go-to CRO partner for biotech visionaries, our therapeutic expertise moves you forward, scales you further, and maximizes your patient impact. Discover our passion for yourself. https://bit.ly/49v5c7v #therapeuticexpertise #patientcentric #patientimpact
要查看或添加评论,请登录
-
The only way to build #drugs that effectively meet #patient needs is by truly understanding the challenges and opportunities of #drugdevelopment. Key opinion leader and Unravel Biosciences’s Chief Medical Officer, Neal Muni, is joining us in this episode of Unraveling Rare to address how Unravel Biosciences is redefining the paradigm of drug development by rapidly discovering compounds that put patients first! Tune in to the full episode to learn more: https://lnkd.in/gHAPZqFF
要查看或添加评论,请登录
-
As a drug developer in a complex industry, you need to remain at the forefront of scientific innovation?while ensuring scientific integrity and responsibility. Join Laura Lotfi on July 18 for a live webinar, Unlock Hidden Insights: Virtual Control Groups as a Data-Driven Novel Method, where she will discuss the practical and regulatory steps for implementing VCGs into future nonclinical studies. https://okt.to/CpQHZm #drugdevelopment #virtualcontrolgroups
要查看或添加评论,请登录
-
-
Informative summary in growing field of radiopharmaceuticals.
RadioPharma Summary from Oppenheimer *38 companies and 45 clinical stage programs, including: 8 Phase III; 9 Phase II; and 28 Phase I/II programs
要查看或添加评论,请登录
-
-
excellent overview of a truly dynamic field. It's great being part of it.
RadioPharma Summary from Oppenheimer *38 companies and 45 clinical stage programs, including: 8 Phase III; 9 Phase II; and 28 Phase I/II programs
要查看或添加评论,请登录
-
-
This important collaboration employs Citeline’s data mastering, subject matter expertise, and technology capabilities to augment its gold standard historical site data, as well as create new predictive algorithms, with the support of Greenphire’s data. As Citeline applies its expertise in data science, analytics and product development to these datasets, it establishes differentiating capabilities not found elsewhere in the market and the opportunity to deploy innovative tools for making more effective, predictive clinical trial decisions. Site level performance data, site capabilities, patient/site burden, budget implications.....the list is endless! #Citeline #Greenphire #AI #ClinicalTrials #Predictive
We are proud to join forces with Greenphire, this partnership is a huge step in how we will create next generation products at Citeline. Read how our complementary datasets will support sponsors and CROs in clinical trial planning! https://ow.ly/zzZq50Tj7vk.
要查看或添加评论,请登录
-
What is new in the news? Read below Citeline Citeline Clinical Greenphire
We are proud to join forces with Greenphire, this partnership is a huge step in how we will create next generation products at Citeline. Read how our complementary datasets will support sponsors and CROs in clinical trial planning! https://ow.ly/zzZq50Tj7vk.
要查看或添加评论,请登录